EDITORIAL
Published on 20 Dec 2022
Editorial: Engineered immune cells in cancer immunotherapy (EICCI)
doi 10.3389/fimmu.2022.1119363
- 1,198 views
- 1 citation
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Engineered Immune Cells in Cancer Immunotherapy (EICCI)
Engineered Immune Cells in Cancer Immunotherapy (EICCI)
167k
Total downloads
606k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
ORIGINAL RESEARCH
Published on 22 Jul 2022
Programmable Attenuation of Antigenic Sensitivity for a Nanobody-Based EGFR Chimeric Antigen Receptor Through Hinge Domain Truncation
doi 10.3389/fimmu.2022.864868
- 3,924 views
- 12 citations
REVIEW
Published on 11 May 2022
Recent Advances in Solid Tumor CAR-T Cell Therapy: Driving Tumor Cells From Hero to Zero?
doi 10.3389/fimmu.2022.795164
- 12,739 views
- 42 citations
ORIGINAL RESEARCH
Published on 22 Apr 2022
Human Tumor Targeted Cytotoxic Mast Cells for Cancer Immunotherapy
doi 10.3389/fonc.2022.871390
- 4,070 views
- 19 citations
REVIEW
Published on 31 Mar 2022
Harnessing the Anti-Tumor Mediators in Mast Cells as a New Strategy for Adoptive Cell Transfer for Cancer
doi 10.3389/fonc.2022.830199
- 2,603 views
- 10 citations
ORIGINAL RESEARCH
Published on 30 Mar 2022
Bibliometric Analysis of Chimeric Antigen Receptor-Based Immunotherapy in Cancers From 2001 to 2021
doi 10.3389/fimmu.2022.822004
- 3,618 views
- 17 citations
ORIGINAL RESEARCH
Published on 18 Mar 2022
A Bibliometric and Knowledge-Map Analysis of CAR-T Cells From 2009 to 2021
doi 10.3389/fimmu.2022.840956
- 11,302 views
- 50 citations
REVIEW
Published on 28 Oct 2021
Optimizing the Clinical Impact of CAR-T Cell Therapy in B-Cell Acute Lymphoblastic Leukemia: Looking Back While Moving Forward
doi 10.3389/fimmu.2021.765097
- 9,148 views
- 25 citations
ORIGINAL RESEARCH
Published on 12 Aug 2021
PTK7-Targeting CAR T-Cells for the Treatment of Lung Cancer and Other Malignancies
doi 10.3389/fimmu.2021.665970
- 8,162 views
- 36 citations
CASE REPORT
Published on 25 May 2021
PiggyBac-Generated CAR19-T Cells Plus Lenalidomide Cause Durable Complete Remission of Triple-Hit Refractory/Relapsed DLBCL: A Case Report
doi 10.3389/fimmu.2021.599493
- 4,550 views
- 12 citations
CASE REPORT
Published on 07 May 2021
Case Report: Prolonged Survival Following EGFRvIII CAR T Cell Treatment for Recurrent Glioblastoma
doi 10.3389/fonc.2021.669071
- 7,895 views
- 49 citations
REVIEW
Published on 03 May 2021
Naturally Occurring Genetic Alterations in Proximal TCR Signaling and Implications for Cancer Immunotherapy
doi 10.3389/fimmu.2021.658611
- 5,472 views
- 6 citations
Published in
Frontiers in Immunology
- Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore
Impact
- 606kTopic views
- 432kArticle views
- 167kArticle downloads